article thumbnail

Outsourcing In Drug Development: A Key Strategy for Sustainable Growth

Electronic Health Reporter

One of the most prominent trends shaping this industry is the outsourcing of various stages of drug development. As companies […] The article Outsourcing In Drug Development: A Key Strategy for Sustainable Growth appeared first on electronichealthreporter.com.

article thumbnail

Daewoong Pharmaceutical revolutionizes drug development with AI-Driven DAISY system

Digital Health Global

Daewoong Pharmaceutical , a prominent player in the South Korean pharmaceutical industry, has unveiled its groundbreaking drug development system, Daewoong AI System (DAISY). About DAISY DAISY represents the culmination of over 40 years of research and development by Daewoong Pharmaceutical.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Pharma – 2025 Health IT Predictions

Healthcare IT Today

This transformation will particularly benefit organizations that can effectively combine AI expertise with traditional pharmaceutical knowledge, creating new competitive advantages in drug development efficiency, cost management, and market responsiveness.

article thumbnail

Weekly Roundup – January 4, 2025

Healthcare IT Today

On the pharma front, expect an emphasis on AI for inventory management and targeted drug development , plus a shake-up in the market for weight-loss drugs. We have plenty more predictions from the Healthcare IT Today community. Read more… 2025 Predictions: Patient Experience.

EHR 94
article thumbnail

Biofourmis announces major agreements with top pharmaceutical companies

Digital Health Global

Driven by Biofourmis’ industry leadership and proven track record in digital biomarker and endpoint development, the agreements bolster the company’s clinical trial programs spanning the United States, Europe, Asia-Pacific, and the Middle East.

article thumbnail

Merative formerly IBM Watson Health poised to launch raft of new products in 2025

Lloyd Price

MarketScan: Offering comprehensive data on healthcare costs and utilisation trends. Clinical Development: Supporting clinical research and development through real-world evidence and advanced analytics. Real-World Evidence: Leverages real-world data to inform clinical decision-making and drug development.

article thumbnail

23andMe announces major Workforce Reduction amid Financial Struggles

Digital Health Global

These developments underscore the ongoing challenges and transformations in both the energy and biotechnology sectors, reflecting broader trends towards sustainability and financial stability. 23andMe tried to monetize its extensive genetic database by collaborating with pharmaceutical companies for drug research.